SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-043443
Filing Date
2019-11-14
Accepted
2019-11-14 13:01:43
Documents
7
Period of Report
2019-11-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K flgt-8k_20191113.htm 8-K 42743
2 EX-1.1 flgt-ex11_203.htm EX-1.1 292227
3 EX-5.1 flgt-ex51_83.htm EX-5.1 21394
4 EX-99.1 flgt-ex991_184.htm EX-99.1 9672
5 EX-99.2 flgt-ex992_204.htm EX-99.2 9717
6 GRAPHIC gsrbyejyqgpm000002.jpg GRAPHIC 6562
7 GRAPHIC gsrbyejyqgpm000001.jpg GRAPHIC 8872
  Complete submission text file 0001564590-19-043443.txt   398581
Mailing Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780
Business Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

IRS No.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37894 | Film No.: 191218444
SIC: 8071 Services-Medical Laboratories